Discover Great Companies Discover Great Clients
Popularity  92.5万   |   Followers  4946   |   Likes  332   |   Feedback  3597 Claim this company

An important representative of traditional Chinese medicine and a busi

No.1 Kunming City Popularity Ranking No.1 Chenggong District No.1 Yunnan Pro No.1 Health No.1 Sheng Wu Ke Ji / Biotechnology Engineering No.1 Health Products No.1 Wellness No.1 Daily Chemicals Products No.1 Skin Healthy No.1 Lao Zi Hao No.1 Zhong Pharmaceuticals No.1 Yi Yao Jing Ji No.1 Raw Materials No.1 Jian Kang Chan Industries No.1 Pharmaceutical Technology 名牌产品 中华老字号 驰名商标 创新型企业 博士后工作站 省技术创新示范企业
More

Company Overview

  • Nature: Listed Company Size: 5000-9999 employees Founded: 33年
  • Industry: Pharmaceuticals/Bioengineering 、 Raw Materials and Processing 、 FMCG (Food/Beverages/Cosmetics)
  • Full name: Yunnan Baiyao Group Co., Ltd.。

Development Stage

  • Stage: 战略投资, 56亿人民币。
  • Ranking: Ranked #1 in Kunming City by popularity Ranked #1 in Kunming Health Company by popularity Ranked #1 in Kunming Sheng Wu Ke Ji / Biotechnology Engineering Company by popularity Ranked #1 in Kunming Health Products Company by popularity Ranked #1 in Kunming Wellness Company by popularity
  • Honors: 2026中国500强 2025中国制造业500强 名牌产品 中华老字号 According to algorithm
  • News: 2026-08-28:云南白药:上半年净利润37.01亿元,同比增长1.88%。
  • Salary: 50.4% of positions earn 4.5-8K, In 2026 vs last yeardecreased by 9%.。Master's salary: ¥20.1K, Doctorate salary: ¥35.1K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 32.9%, "Computer/Network/Technology": 7.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 7.6%。
  • Recruiting: In 2026 vs 2025grew by 25%. Demand for highly educated talent: Master's: 55, Doctorate: 10.
  • Requirement: Education: 本科 leads with 85.8%. Experience: 不限 leads with 36.4%.
  • Region: Distributed across 81 regions, 昆明: 26.8%, 北京: 4.4%, 杭州: 4.3%, 上海: 4.1%.

About the Company

[Summary] An important representative of traditional Chinese medicine and a busi

Yunnan Baiyao is a century-old time-honored Chinese brand created in 1902, a well-known trademark in China, and one of the first batch of national innovative enterprises. Since 2006, the company's main economic indicators have steadily ranked among the top in the national traditional Chinese medicine industry. In September 2021, MSCI upgraded its ESG (Environmental, Social, and Governance) rating of Yunnan Baiyao, making it the highest-rated and the first A-rated listed company in Yunnan Province, as well as the highest-rated and the first A-rated (or above) pharmaceutical company on the Shenzhen stock market. The company adheres to innovative development, reshaping the multi-brand system of Yunnan Baiyao through technological, product, and management innovation, and striving to build a complete pharmaceutical industry chain. Its business covers Chinese medicine resources, Chinese and Western medicine raw materials/preparations, personal care products, health and wellness, and commercial distribution, successfully extending its pharmaceutical brand to health and service brands. In the Chinese brand rankings released by Interbrand, Hurun, and BrandZ, it has consistently ranked first in the industry.

■ We have always been committed to self-breakthroughs, continuously surpassing new goals.

Yunnan Baiyao was established as a factory in 1971 under the instructions of Premier Zhou Enlai, listed on the Shenzhen Stock Exchange in 1993 as the first listed company in Yunnan, achieved complete brand unification in 1996, successfully implemented corporate restructuring in 1999, launched the "Stabilize the Central, Highlight the Two Wings" product strategy in 2005, and began implementing the "New Baiyao, Big Health" industrial strategy in 2010, gradually developing from a proprietary Chinese medicine enterprise into one of the leading enterprises in China's big health industry. In 2016, Yunnan Baiyao implemented mixed-ownership reform at the holding level through capital increase and share expansion, absorbing over 20 billion yuan in private capital from Xinhua Du and Jiangsu Yuyue. In April 2019, with the approval of the China Securities Regulatory Commission, Yunnan Baiyao Group Co., Ltd. absorbed and merged Yunnan Baiyao Holdings Co., Ltd., achieving overall listing. State-owned and private capital stood side by side as the two largest shareholders, rationalizing the system and activating mechanisms. Due to its thoroughness and pioneering nature, Baiyao's mixed-ownership reform has been praised as the "Baiyao Model." In December 2019, Yunnan Baiyao ranked 66th on the 2019 Hurun Brand List with a brand value of 25.5 billion yuan, ranking first in the healthcare industry for consecutive years and remaining on the list for 11 consecutive years. In July 2020, Yunnan Baiyao was selected as one of the "Top 500 Chinese Listed Companies by Market Value," ranking 140th. In July 2021, Yunnan Baiyao was selected as one of the "Top 25 Global Pharmaceutical Brand Value" and as "China's Strongest Pharmaceutical Brand."

In the future, Yunnan Baiyao will globally allocate resources to address the Chinese market, adhere to the development approach of both endogenous growth and exogenous expansion, focus on networking, platformization, and ecosystem building, strengthen competitive strength, continuously provide leading comprehensive pharmaceutical and health solutions to customers, build a sustainable century-old foundation, and strive to become a national team representing China's big health enterprises in global competition.

■ Through continuous innovation and progress, Yunnan Baiyao has gained full recognition from all sectors of society.

Top 50 Global Pharmaceutical Enterprises ------------ China Time-honored Brand
Fortune China 500 ------------ National Brand Plan
BrandZ™ China's Top 50 Brands ------------ China Industrial Grand Award
Asia's Best Listed Companies Top 50 ------------ Forbes World's Best Employers List
Top 100 Most Valuable Brands ------------ First Prize of the National Science and Technology Progress Award

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Yunnan Baiyao Financing History (2 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 56亿人民币
  • Investor: 鱼跃医疗

Yunnan Baiyao How Fast Is Hiring Growing? (355 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 32%
  • 2024: Up 24%
  • 2023: Up 76%
  • 2022: Down 73%
Yunnan Baiyao Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Yunnan Baiyao Campus Recruitment & Advanced Degree Talent Demand
Graduates 8 Interns 12 Master's 55 Doctorate 10
No.2
Company Recruitment Ranking in Kunming City 򀀩
No.329
Recruitment Growth Ranking in Kunming City 򀀩
No.5
Graduate Talent Ranking in Kunming City 򀀩
No.3
Intern Talent Ranking in Kunming City 򀀩
Note: How fast is hiring at Yunnan Baiyao Group Co., Ltd. growing? Yunnan Baiyao2026: 1282 openings (up 25%), 2025: 1022 openings (up 32%), 2024: 777 openings (up 24%), 2023: 627 openings (up 76%), 2022: 356 openings (down 73%), 2021: 1302 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Yunnan Baiyao Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 14%
  • 2024: Up 40%
  • 2023: Down 32%
  • 2022: Up 164%
Yunnan Baiyao Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Yunnan Baiyao Group Co., Ltd. growing? Yunnan BaiyaoMaster's recruitment over the years: 2025: 72 openings (up 14%), 2024: 63 openings (up 40%), 2023: 45 openings (down 32%), 2022: 66 openings (up 164%), 2021: 25 openings. Yunnan Baiyao master talent ranking in Kunming: #3, Yunnan Baiyao master salary mostly around 10-30K.

Yunnan Baiyao Doctoral Degree Job Demand Analysis

(More)
+80%
Growth Rate
2026 vs 2025
  • 2025: Up 186%
  • 2024: Down 13%
  • 2023: Down 20%
  • 2022: Up 150%
Yunnan Baiyao Doctoral Hiring by Year: 2026 — 16 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Yunnan Baiyao Group Co., Ltd. growing? Yunnan BaiyaoDoctorate recruitment over the years: 2026: 36 openings (up 80%), 2025: 20 openings (up 186%), 2024: 7 openings (down 13%), 2023: 8 openings (down 20%), 2022: 10 openings (up 150%), 2021: 4 openings. Yunnan Baiyao doctorate talent ranking in Kunming: #3, Yunnan Baiyao doctorate salary mostly around 20-50K.

Yunnan Baiyao R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Yunnan Baiyao Group Co., Ltd.? Based on an analysis of Yunnan Baiyao's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 32.9%, "Computer/Network/Technology": 7.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 7.6%, "Other (R&D and Technical)": 7.1%, "Scientific Research": 5%, "Art/Design/Creative": 0.7%. For reference only.

Yunnan Baiyao — What Are the Salaries Like? (1595 records)

Manage
salary range: 3K - 30K, 50.4% of roles pay ¥4.5-8K
Note: salary statistics are based on 1595 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Yunnan Baiyao Group Co., Ltd.?Yunnan Baiyao50.4% of positions earn 4.5-8K, Fresh graduate salary: ¥7.1K。Kunming salary ranking top 20,医疗卫生/美容保健类 average salary ¥9.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Yunnan Baiyao

(More)
Are salaries high at Yunnan Baiyao Group Co., Ltd.? We provide: 临床, OTC Representative, Researcher, Operations, Finance Specialist, Business Development, Sales Representative, Sales, BP, Product Manager, Store Manager, Quality, Analyst, Vice President, Intern, bm, Channel Manager, Regional Sales Representative, Business Specialist, Makeup Artist. Click to view detailed salary analysis by job.

Yunnan Baiyao — Fortune 500? (More)

Yes, ranked in 中国500强:

  • NO.366 2026中国500强 >
  • NO.357 2025中国500强 >
  • NO.385 2024中国500强 >

Yes, ranked in 中国制造业500强:

  • NO.303 2025中国制造业500强 >
  • NO.296 2024中国制造业500强 >
  • NO.282 2021中国制造业500强 >

Job Category

  • 医疗卫生/美容保健类
    32.9% of total 32.9%
  • 销售类
    31.8% of total 31.8%
  • 客户服务类
    9.2% of total 9.2%
  • 市场/公关/媒介类
    8.1% of total 8.1%

Education

  • 本科
    85.8% of total 85.8%
  • 硕士
    7.5% of total 7.5%
  • 博士
    2.7% of total 2.7%
  • 大专
    1.9% of total 1.9%

Experience

  • 不限
    36.4% of total 36.4%
  • 1-3年
    34.2% of total 34.2%
  • 3-5年
    19.7% of total 19.7%
  • 5-10年
    8.8% of total 8.8%
View Detailed Analysis

What does Yunnan Baiyao Group Co., Ltd. require? Who is Yunnan Baiyao hiring? Yunnan Baiyao recruitment: 医疗卫生/美容保健类占比最多占32.9%,其次是销售类占31.8%. What education can get in at Yunnan Baiyao? 本科占比最多占85.8%,其次是硕士占7.5%. High education required at Yunnan Baiyao? 硕士占7.5%,博士占2.7%. Work experience required at Yunnan Baiyao? 不限占比最多占36.4%,其次是1-3年占34.2%. Where are the job locations at Yunnan Baiyao? 昆明占比最多占26.8%,其次是北京占4.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 178,426.2603万(元)
Legal Representative: 张文学
Date Established:
Credit Code: 9153000021652214XX
Registered Address: 云南省昆明市呈贡区云南白药街3686号

Partners & Suppliers

向曲靖六十九医院供应中成药及西药 Source
合作客户 药品供应
九州通采购云南白药的药品。 Source
合作客户 中药
南京医药作为云南白药气雾剂、创可贴等消费品类江苏零售渠道配送商 Source
合作客户 中成药
战略合作,共建共享渠道,互相销售对方产品,联合研发。 Source
供应商 医药工业战略合作
云南白药战略入股上海医药,双方在药品分销、中药开发、健康品等领域深度合作 Source
供应商 战略投资与合资公司

People who follow Yunnan Baiyao also follow

Yunnan Baiyao Competitors (Similar Companies)

“Let people share the health and happiness brought by technology”
“Building China's skin health ecosystem and promoting the development o”
“Comprehensive fertilizer manufacturer”
“Help farmers raise good pigs, let consumers eat good meat”
“Green KPC, Benefits Society”
“Retail pharmacy chain”
工程咨询 工程设计 工程勘察 市政工程
“Tianxia Tongwen / One world one family”
制药/药业 医药 生物科技/生物工程 医药工业
制药/药业 医药 生物医药 新药研发
“Providing first-class solutions for global new energy applications”
“Research, development, and production of anti-tumor and surgical medic”
“To develop high-quality biologics that are accessible and affordable f”
乳业 奶粉 酸奶 食品
磷酸 磷矿石 磷酸盐 磷化工

Discover Great Companies, Discover Great Clients

昆明公司名录 昆明“Chenggong District”公司名录 昆明“大健康”公司名录 昆明“中药材”公司名录 昆明“日化/日用化工”公司名录 昆明“中成药”公司名录 昆明“化妆品”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates